Monitoring by three laboratory methods of an oral GPIIb/IIIa anti-platelet agent in patients with vascular disease

被引:0
|
作者
Ledford, MR
Canton, M
Preston, R
Gretler, DD
Enten, J
Alonso, A
Brito, MI
Delgado, L
Mitchell, M
机构
[1] Univ Miami, Sch Med, Dept Pathol, Miami, FL 33152 USA
[2] Univ Miami, Sch Med, Dept Clin Pharmacol, Miami, FL 33152 USA
[3] Biocytex, Miami, FL USA
[4] COR Therapeut Inc, Marseille, France
[5] Beckman Coulter Corp, S San Francisco, CA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2601
引用
收藏
页码:821 / 821
页数:1
相关论文
共 50 条
  • [31] ANTI-PLATELET AGENTS IN DIABETIC LOWER-EXTREMITY VASCULAR-DISEASE - A VA COOPERATIVE STUDY
    COLWELL, J
    THROMBOSIS AND HAEMOSTASIS, 1981, 46 (01) : 91 - 91
  • [32] Spinal Cord Stimulation With Percutaneous Paddle Electrode For Peripheral Vascular Disease Under Anti-platelet Therapy
    Goto, Shinichi
    Shimizu, Noritaka
    Tanaka, Toshiyuki
    Narumiya, Kazutoshi
    STEREOTACTIC AND FUNCTIONAL NEUROSURGERY, 2013, 91 : 297 - 297
  • [33] Cigarette smoking inhibits the anti-platelet activity of aspirin in patients with coronary heart disease
    LI WeijuZHANG HongyinMIAO ChenglongTANG RiboDU XinSHI Jihui and MA Changsheng Department of CardiologyPeking University HospitalBeijing China Department of CardiologyBeijing Anzhen HospitalCapital Medical UniversityBeijing China
    中华医学杂志(英文版), 2011, (10) : 1569 - 1572
  • [34] EFFECTS OF AN ANTI-PLATELET DRUG ON MYOCARDIAL ISCHEMIA IN PATIENTS WITH CORONARY-ARTERY DISEASE
    SELWYN, A
    JONATHAN, A
    FOX, K
    AMERICAN JOURNAL OF CARDIOLOGY, 1980, 45 (02): : 424 - 424
  • [35] Cigarette smoking inhibits the anti-platelet activity of aspirin in patients with coronary heart disease
    Li Wei-ju
    Zhang Hong-yin
    Miao Cheng-long
    Tang Ri-bo
    Du Xin
    Shi Ji-hui
    Ma Chang-sheng
    CHINESE MEDICAL JOURNAL, 2011, 124 (10) : 1569 - 1572
  • [36] Evaluation of Resistance to Anti-platelet Therapy in Patients with Coronary Heart Disease in a Developing Country
    Al Shamiri, Mostafa Q.
    Gader, Abelgalil M. Abdel
    Bayoumy, Nervana M.
    CLINICAL LABORATORY, 2014, 60 (09) : 1449 - 1455
  • [37] Anti-platelet Therapy Is Associated With Lower Risk of Dementia in Patients With Cerebral Small Vessel Disease
    Pan, Dong
    Rong, Xiaoming
    Li, Honghong
    Deng, Zhenhong
    Wang, Jia
    Liu, Xiaohuan
    He, Lei
    Xu, Yongteng
    Tang, Yamei
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [38] Chronic inhibition of the platelet glycoprotein IIb/IIIa by a new oral agent: a dose-escalation study in patients with coronary artery disease (CAD)
    CatellaLawson, F
    Kapoor, S
    Skammer, W
    Fitzgerald, DJ
    Rocca, B
    Tamby, JF
    FitzGerald, GA
    THROMBOSIS AND HAEMOSTASIS, 1997, : O1602 - O1602
  • [39] Pharmacogenomics of anti-platelet therapy focused on peripheral blood cells of coronary arterial disease patients
    Luchessi, Andre Ducati
    Silbiger, Vivian Noguiea
    Crespo Hirata, Rosario Dominguez
    Lima-Neto, Lidio Goncalves
    Cavichioli, Debora
    Iniguez, Andres
    Bravo, Marisol
    Bastos, Guillermo
    Morais Rego Sousa, Amanda Guerra
    Brion, Maria
    Carracedo, Angel
    Hirata, Mario Hiroyuki
    CLINICA CHIMICA ACTA, 2013, 425 : 9 - 17
  • [40] The prophylactic effect of anti-platelet agent Beraprost on development of atherosclerosis of the carotid artery in type 2 diabetic patients
    Sanke, T
    Nakagawa, T
    Anaguchi, R
    Nanjo, K
    Ueda, K
    DIABETES, 1999, 48 : A126 - A126